Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity.

Masoud MirghorbaniAli RashidiniaMehdi YaseriMohammad ZareiHassan KhojastehFatemeh BazvandBobeck S Modjtahedi

Published in: International journal of retina and vitreous (2022)

This study revealed that pre-treatment ROP zone was associated with ROP reactivation rate but not with time to full vascularization in those treated with IVB. Trial registration Retrospectively registered; IR.TUMS.FARABI.REC.1399.040.

Keyphrases

vascular endothelial growth factor
endothelial cells
diabetic retinopathy
clinical trial
phase iii
tissue engineering
stem cells
phase ii
mesenchymal stem cells
bone marrow
combination therapy
open label